Cigna Group (CI) stock
CINYSEHospital & Medical Service PlansFiscal year ends December 31
$285.37−8.69 (-2.96%)
Close on Nov 18, 2026Market cap $75.41BP/E –Yield 2.12%
Cigna gross profit
Gross profit is revenue minus the direct cost of the goods and services sold.
Cigna's gross profit for the twelve months ending Jun 30, 2026 was $58.25B, down 8.7% year over year. For fiscal 2025 it was $59.91B, down 7.3% from the year before. The highest annual figure on record is $64.61B in fiscal 2024.
Annual gross profit
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $59.91B | -7.3% |
| FY2024 | Dec 31, 2024 | $64.61B | +5.1% |
| FY2023 | Dec 31, 2023 | $61.46B | +10.4% |
| FY2022 | Dec 31, 2022 | $55.68B | -1.5% |
| FY2021 | Dec 31, 2021 | $56.52B | -0.7% |
| FY2020 | Dec 31, 2020 | $56.92B | +1.8% |
| FY2019 | Dec 31, 2019 | $55.90B | +27.5% |
| FY2018 | Dec 31, 2018 | $43.86B | +11.5% |
| FY2017 | Dec 31, 2017 | $39.35B | +5.3% |
| FY2016 | Dec 31, 2016 | $37.37B | – |
Quarterly gross profit
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $14.97B | +7.6% |
| Q1 FY2026 | Mar 31, 2026 | $14.39B | -15.8% |
| Q4 FY2025 | Dec 31, 2025 | $14.68B | -11.7% |
| Q3 FY2025 | Sep 30, 2025 | $14.22B | -11.8% |
| Q2 FY2025 | Jun 30, 2025 | $13.91B | -13.2% |
| Q1 FY2025 | Mar 31, 2025 | $17.10B | +8.1% |
| Q4 FY2024 | Dec 31, 2024 | $16.63B | +4.9% |
| Q3 FY2024 | Sep 30, 2024 | $16.13B | +4.7% |
| Q2 FY2024 | Jun 30, 2024 | $16.03B | +5.9% |
| Q1 FY2024 | Mar 31, 2024 | $15.82B | +5.1% |
| Q4 FY2023 | Dec 31, 2023 | $15.85B | +16.1% |
| Q3 FY2023 | Sep 30, 2023 | $15.41B | +14.1% |
| Q2 FY2023 | Jun 30, 2023 | $15.14B | +5.7% |
| Q1 FY2023 | Mar 31, 2023 | $15.06B | +6.1% |
| Q4 FY2022 | Dec 31, 2022 | $13.66B | -5.4% |
| Q3 FY2022 | Sep 30, 2022 | $13.50B | -5.0% |
| Q2 FY2022 | Jun 30, 2022 | $14.33B | +1.4% |
| Q1 FY2022 | Mar 31, 2022 | $14.19B | +3.3% |
| Q4 FY2021 | Dec 31, 2021 | $14.43B | -1.5% |
| Q3 FY2021 | Sep 30, 2021 | $14.22B | -0.8% |
| Q2 FY2021 | Jun 30, 2021 | $14.13B | +3.5% |
| Q1 FY2021 | Mar 31, 2021 | $13.74B | -3.8% |
| Q4 FY2020 | Dec 31, 2020 | $14.65B | +3.6% |
| Q3 FY2020 | Sep 30, 2020 | $14.33B | +2.3% |
| Q2 FY2020 | Jun 30, 2020 | $13.65B | -1.5% |
| Q1 FY2020 | Mar 31, 2020 | $14.28B | +2.8% |
| Q4 FY2019 | Dec 31, 2019 | $14.14B | +25.3% |
| Q3 FY2019 | Sep 30, 2019 | $14.00B | +29.0% |
| Q2 FY2019 | Jun 30, 2019 | $13.86B | +27.5% |
| Q1 FY2019 | Mar 31, 2019 | $13.90B | +28.1% |
| Q4 FY2018 | Dec 31, 2018 | $11.28B | – |
| Q3 FY2018 | Sep 30, 2018 | $10.86B | – |
| Q2 FY2018 | Jun 30, 2018 | $10.87B | – |
| Q1 FY2018 | Mar 31, 2018 | $10.85B | – |
See a number that looks wrong?